Skip to main content

Table 4 Cost effectiveness results in the ward model of hospitalized community-acquired pneumonia in the elderly according to antibiotic regimen. Increment cost, utility, and cost/utility ratio were estimated relative to adherent as the base comparator

From: Cost effectiveness of adherence to IDSA/ATS guidelines in elderly patients hospitalized for Community-Aquired Pneumonia

 

Adherent

Over-Treated

Under-Treated

Cost ($)

10,156 (4665 – 17,585)

11,535 (5339 – 20,179)

10,954 (5159-19,190)

Incremental Cost ($)

 

+1379 (−8418 – 11,448)

+799 (−8875 – 10,940)

Utility

11.2 (8.9 – 12.5)

10.1 (7.2 – 12.1)

10.5 (7.9 – 12.1)

Incremental Utility

 

−1.0 (−4.2−1.9)

−0.7 (−3.6–2.0)

  1. Estimates presented as means (2.5th-97.5th percentile). Costs are in 2013 US dollars